Inge Sokilde Pedersen
Overview
Explore the profile of Inge Sokilde Pedersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
OMahony D, Ramus S, Southey M, Meagher N, Hadjisavvas A, John E, et al.
Br J Cancer
. 2023 Apr;
128(12):2283-2294.
PMID: 37076566
Background: The distribution of ovarian tumour characteristics differs between germline BRCA1 and BRCA2 pathogenic variant carriers and non-carriers. In this study, we assessed the utility of ovarian tumour characteristics as...
12.
Ladekarl M, Nohr A, Sonderkaer M, Dahl S, Sunde L, Vestereghem C, et al.
Acta Oncol
. 2023 Mar;
62(3):261-271.
PMID: 36905645
Aim: Our goal was to describe a precision medicine program in a regional academic hospital, characterize features of included patients and present early data on clinical impact. Materials And Methods:...
13.
Terp S, Pontoppidan Stoico M, Dybkaer K, Pedersen I
Clin Epigenetics
. 2023 Feb;
15(1):24.
PMID: 36788585
Patients diagnosed with epithelial ovarian cancer (OC) have a 5-year survival rate of 49%. For early-stage disease, the 5-year survival rate is above 90%. However, advanced-stage disease accounts for most...
14.
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, et al.
Genet Med
. 2022 Oct;
24(10):2208.
PMID: 36205748
No abstract available.
15.
Hakkaart C, Pearson J, Marquart L, Dennis J, Wiggins G, Barnes D, et al.
Commun Biol
. 2022 Oct;
5(1):1061.
PMID: 36203093
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals with pathogenic BRCA1 or BRCA2 variants remains relatively unknown. We conducted the largest genome-wide analysis...
16.
Krarup K, Rantanen J, Mork M, Pedersen I, Christensen J, Kristensen S, et al.
Sports Med Int Open
. 2022 Jul;
6(1):E39-E46.
PMID: 35874049
The effect of long gaming sessions on energy intake, caffeine intake, blood pressure, heart rate, heart rate variability, and biochemical cardiac injury markers is unknown. The objective of this exploratory...
17.
Dareng E, Tyrer J, Barnes D, Jones M, Yang X, Aben K, et al.
Eur J Hum Genet
. 2022 Mar;
30(5):630-631.
PMID: 35314806
No abstract available.
18.
Li S, Silvestri V, Leslie G, Rebbeck T, Neuhausen S, Hopper J, et al.
J Clin Oncol
. 2022 Jan;
40(14):1529-1541.
PMID: 35077220
Purpose: To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in and for effective cancer risk management. Methods: We...
19.
Dareng E, Tyrer J, Barnes D, Jones M, Yang X, Aben K, et al.
Eur J Hum Genet
. 2022 Jan;
30(3):349-362.
PMID: 35027648
Polygenic risk scores (PRS) for epithelial ovarian cancer (EOC) have the potential to improve risk stratification. Joint estimation of Single Nucleotide Polymorphism (SNP) effects in models could improve predictive performance...
20.
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, et al.
Genet Med
. 2021 Dec;
24(1):119-129.
PMID: 34906479
Purpose: Germline genetic testing for BRCA1 and BRCA2 variants has been a part of clinical practice for >2 decades. However, no studies have compared the cancer risks associated with missense...